Drawing for EXPRESSWELL

USPTO serial 98101090

EXPRESSWELL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LINCOSKI JR, JOHN T
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXPRESSWELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Neelam Singh

Neelam Singh SINGH LAW PRACTICE, LLC403 6TH AVENUESUITE 12BROOKLYN, NY 11215

Goods and services

ClassDescriptionStatusFirst use
044Health care; Health care services for treating gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin and mineral deficiencies; Health care services, namely, hemorrhoid treatment, infusion therapy, urgent care, primary health care and women's health care; Health assessment services; Health center services; Individual medical counseling services provided to patients; Integrated outpatient health care services; Intravenous (IV) hydration therapy services; Medical analysis services relating to the treatment of persons; Medical diagnosis and treatment of gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune disorders, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin or mineral deficiencies; Medical evaluation of gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin and mineral deficiencies; Medical examination services; Medical services in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Medical services, namely, treating gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune disorders, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional and vitamin or mineral deficiencies; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis for the diagnosis and treatment of persons; Medical screening; Medical services; Outpatient and inpatient care services; Physical fitness assessment services for medical purposes; Primary care medical services; Providing health information; Providing medical information via a website; Providing personalized healthcare and medical information in the nature of gastrointestinal health, perianal health, women's health and infusion therapy; Telemedicine services; Urgent medical care centers; Conducting medical physical evaluations; Health clinic services; Medical clinic services; Medical clinics; Providing health care information by telephone; Providing health care information by telephone and the internet; Providing medical advice in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Providing medical information in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Provision of medical information; Provision of medical services by health care professionals via the internet or telecommunication networks; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Walk-in medical clinic servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 16, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 16, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 1, 2025DOCKASSIGNED TO EXAMINER—
Nov 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2024EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2024EXT1SOU EXTENSION 1 FILED—
Nov 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 30, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 28, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 28, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 28, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 28, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 27, 2024DOCKASSIGNED TO EXAMINER—
Aug 23, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance